drugdeliverybusiness6d
Class action suit targets Abbott FreeStyle Libre amid claims of data sharing
Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...
medtechdive4d
Abbott ramps up Libre 3 production amid shortages
Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.
Medpage Today on MSN16d
FreeStyle Libre 3 Sensor Class I Recall; Second OTC CGM Cleared; Weekly Insulin Win
The FDA designated Abbott's recall of FreeStyle Libre 3 sensors as the most serious, class I type due to the risk for ...
Abbott's Still Crushing It
Abbott's strong innovation pipeline, including advancements in CGM systems, supports its market share gains and growth ...
The Bryan Times15d
Certain FreeStyle Libre 3 sensors recalled due to risk for inaccurate high glucose readings
Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...